EAM Investors, LLC - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 144 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.8%.

Quarter-by-quarter ownership
EAM Investors, LLC ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q2 2020$2,710,000
+159.1%
129,799
+21.3%
0.60%
+84.3%
Q1 2020$1,046,000
-62.1%
107,030
-53.9%
0.32%
-51.9%
Q2 2019$2,759,000232,0430.68%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q2 2020
NameSharesValueWeighting ↓
Versant Venture Management, LLC 5,068,233$17,739,0005.88%
Sonic Fund II, L.P. 6,552,068$22,932,0001.69%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 480,000$1,680,0000.88%
Avoro Capital Advisors LLC 6,950,000$24,325,0000.42%
RTW INVESTMENTS, LP 7,357,917$25,753,0000.39%
K2 PRINCIPAL FUND, L.P. 898,307$3,144,0000.26%
Artal Group S.A. 3,000,000$10,500,0000.21%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,827,000$9,895,0000.18%
WS MANAGEMENT LLLP 307,442$1,076,0000.11%
ALGERT GLOBAL LLC 82,145$288,0000.10%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders